Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG

被引:316
作者
Carter, Stephen F.
Scholl, Michael
Almkvist, Ove [2 ]
Wall, Anders [3 ]
Engler, Henry [3 ,4 ]
Langstrom, Bengt [5 ,6 ]
Nordberg, Agneta [1 ,7 ]
机构
[1] Karolinska Inst, Div Alzheimer Neurobiol Ctr, Dept Neurobiol Care Sci & Soc, S-14186 Stockholm, Sweden
[2] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden
[3] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden
[4] Uruguayan Ctr Mol Imaging CUDIM, Montevideo, Uruguay
[5] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden
[6] Univ London Imperial Coll Sci Technol & Med, Div Expt Med, Neuropsychopharmacol Unit, London, England
[7] Karolinska Univ Hosp Huddinge, Dept Geriatr Med, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Alzheimer disease; mild cognitive impairment; PET; astrocytosis; amyloid; monoamine oxidase B; POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; MONOAMINE-OXIDASE-B; HUMAN-BRAIN; MAO-B; CLINICAL PROGRESSION; MICROGLIA; INHIBITOR; DIAGNOSIS; HEALTH;
D O I
10.2967/jnumed.110.087031
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Astrocytes colocalize with fibrillar amyloid-beta (A beta) plaques in postmortem Alzheimer disease (AD) brain tissue. It is therefore of great interest to develop a PET tracer for visualizing astrocytes in vivo, enabling the study of the regional distribution of both astrocytes and fibrillar A beta. A multitracer PET investigation was conducted for patients with mild cognitive impairment (MCI), patients with mild AD, and healthy controls using C-11-deuterium-L-deprenyl (C-11-DED) to measure monoamine oxidase B located in astrocytes. Along with C-11-DED PET, C-11-Pittsburgh compound B (C-11-PIB; fibrillar A beta deposition), F-18-FDG (glucose metabolism), T1 MRI, cerebrospinal fluid, and neuropsychologic data were acquired from the patients. Methods: C-11-DED PET was performed in MCI patients (n = 8; mean age 6 SD, 62.6 +/- 7.5 y; mean Mini Mental State Examination, 27.5 +/- 2.1), AD patients (n = 7; mean age, 65.1 +/- 6.3 y; mean Mini Mental State Examination, 24.4 +/- 5.7), and healthy age-matched controls (n = 14; mean age, 64.7 +/- 3.6 y). A modified reference Patlak model, with cerebellar gray matter as a reference, was chosen for kinetic analysis of the C-11-DED data. C-11-DED data from 20 to 60 min were analyzed using a digital brain atlas. Mean regional F-18-FDG uptake and C-11-PIB retention were calculated for each patient, with cerebellar gray matter as a reference. Results: ANOVA analysis of the regional C-11-DED binding data revealed a significant group effect in the bilateral frontal and bilateral parietal cortices related to increased binding in the MCI patients. All patients, except 3 with MCI, showed high C-11-PIB retention. Increased C-11-DED binding in most cortical and subcortical regions was observed in MCI C-11-PIB+ patients relative to controls, MCI C-11-PIB (negative) patients, and AD patients. No regional correlations were found between the 3 PET tracers. Conclusion: Increased C-11-DED binding throughout the brain of the MCI C-11-PIB+ patients potentially suggests that astrocytosis is an early phenomenon in AD development.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 39 条
  • [1] Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease
    Anchisi, D
    Borroni, B
    Franceschi, M
    Kerrouche, N
    Kalbe, E
    Beuthien-Beumann, B
    Cappa, S
    Lenz, O
    Ludecke, S
    Marcone, A
    Mielke, R
    Ortelli, P
    Padovani, A
    Pelati, O
    Pupi, A
    Scarpini, E
    Weisenbach, S
    Herholz, K
    Salmon, E
    Holthoff, V
    Sorbi, S
    Fazio, F
    Perani, D
    [J]. ARCHIVES OF NEUROLOGY, 2005, 62 (11) : 1728 - 1733
  • [2] Unified segmentation
    Ashburner, J
    Friston, KJ
    [J]. NEUROIMAGE, 2005, 26 (03) : 839 - 851
  • [3] Bartenstein P, 1997, J NUCL MED, V38, P1095
  • [4] The importance of impaired physical health and age in normal cognitive aging
    Bergman, Ingvar
    Blomberg, Mari
    Almkvist, Ove
    [J]. SCANDINAVIAN JOURNAL OF PSYCHOLOGY, 2007, 48 (02) : 115 - 125
  • [5] Temporal lobe epilepsy visualized with PET with 11C-L-deuterium-deprenyl -: analysis of kinetic data
    Bergstrom, M
    Kumlien, E
    Lilja, A
    Tyrefors, N
    Westerberg, G
    Langstrom, B
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1998, 98 (04): : 224 - 231
  • [6] In-vivo measurement of activated microglia in dementia
    Cagnin, A
    Brooks, DJ
    Kennedy, AM
    Gunn, RN
    Myers, R
    Turkheimer, FE
    Jones, T
    Banati, RB
    [J]. LANCET, 2001, 358 (9280) : 461 - 467
  • [7] Amyloid, hypometabolism, and cognition in Alzheimer disease - An [11C]PIB and [18F]FDG PET study
    Edison, P.
    Archer, H. A.
    Hinz, R.
    Hammers, A.
    Pavese, N.
    Tai, Y. F.
    Hotton, G.
    Cutler, D.
    Fox, N.
    Kennedy, A.
    Rossor, M.
    Brooks, D. J.
    [J]. NEUROLOGY, 2007, 68 (07) : 501 - 508
  • [8] Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study
    Edison, Paul
    Archer, Hilary A.
    Gerhard, Alexander
    Hinz, Rainer
    Pavese, Nicola
    Turkheimer, Federico E.
    Hammers, Alexander
    Tai, Yen Fong
    Fox, Nick
    Kennedy, Angus
    Rossor, Martin
    Brooks, David J.
    [J]. NEUROBIOLOGY OF DISEASE, 2008, 32 (03) : 412 - 419
  • [9] Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease
    Engler, H
    Lundberg, PO
    Ekbom, K
    Nennesmo, I
    Nilsson, A
    Bergström, M
    Tsukada, H
    Hartvig, P
    Långström, B
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (01) : 85 - 95
  • [10] Translational neuroimaging: Positron emission tomography studies of monoamine oxidase
    Fowler, JS
    Logan, J
    Volkow, ND
    Wang, GJ
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2005, 7 (06) : 377 - 387